Europa · Agencias y tiempo real · Reuters

Novo Nordisk hikes 2026 outlook again as Wegovy pill beats forecasts

Publicado por Reuters · Reino Unido hace 9 h

Novo Nordisk's ‌Wegovy weight-loss pill beat third-quarter sales forecasts and the drug maker lifted its full-year outlook again on Wednesday, boosting efforts to regain lost…

Leer el artículo completo en Reuters Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.reuters.com)

Novo Nordisk hikes 2026 outlook again as Wegovy pill beats forecasts

También te puede interesar

Armenian security officers detain opposition leader Karapetyan

US trade deficit narrows to $105B in September as exports rise

Prediction markets get Democratic win right, with a few surprises

TAILG Showcases Long-Range Technology and a Versatile Product Lineup at EICMA 2026

Revolut's rise to become Europe's $115 billion big bank rival

BMW tune-up fixes today’s problem not tomorrow’s

Novo Nordisk hikes 2026 outlook again as Wegovy pill beats forecasts

Compartir

También te puede interesar

Armenian security officers detain opposition leader Karapetyan

US trade deficit narrows to $105B in September as exports rise

Prediction markets get Democratic win right, with a few surprises

TAILG Showcases Long-Range Technology and a Versatile Product Lineup at EICMA 2026

Revolut's rise to become Europe's $115 billion big bank rival

BMW tune-up fixes today’s problem not tomorrow’s